205
Participants
Start Date
October 25, 2021
Primary Completion Date
February 15, 2024
Study Completion Date
February 15, 2024
Continuation or discontinuation of oxytocin during the active first stage of labor (≥6 cm dilation).
"At the intervention site (Foothills Medical Centre), for participants who consent to being part of the trial, once a patient is found to be \>= 6 cm dilation, the study medication will be initiated. Pharmacy will make up identical vials of oxytocin or saline, which will be numbered according to the random allocation sequence created by the study statistician.~The intervention will be continued until delivery unless contractions decrease to less than 2 in 10 minutes or if no further cervical dilation is noted 4 hours after discontinuation."
University of Calgary, Calgary
University of Calgary
OTHER